$IBB Headlines Charting the S&P 500’s precarious

New Post Public Reply Private Reply Replies (0) Message Board

Sep 29, 2014 at 10:07 AM

$IBB Headlines

Charting the S&P 500’s precarious posture 10:44 a.m. Sept. 25, 2014 - Michael Ashbaugh
Nasdaq balks at the September peak 10:40 a.m. Sept. 22, 2014 - Michael Ashbaugh
U.S. stocks end lower; tech and small-caps lead losses 4:09 p.m. Sept. 15, 2014 - Karen Friar
Stock-picking gains traction as volatility looms 6:01 a.m. Sept. 7, 2014 - Wallace Witkowski
S&P clears the 2,000 mark, reaches uncharted territory 11:49 a.m. Aug. 26, 2014 - Michael Ashbaugh
S&P clears the 2,000 mark, reaches uncharted territory 11:35 a.m. Aug. 26, 2014 - Michael Ashbaugh
This one stock sector can withstand all the ‘bubble’ talk 6:00 a.m. Aug. 21, 2014 - Jeff Reeves
S&P 500 retests the breakdown point 11:17 a.m. Aug. 14, 2014 - Michael Ashbaugh
U.S. stocks push higher; biotechs rally 4:06 p.m. Aug. 13, 2014 - Carla Mozee
Dow, S&P 500 inch up, while Nasdaq, Russell 2000 slip: stock market live blog recap 3:34 p.m. July 28, 2014 - blogs.marketwatch.com
Momentum plays stabilize: Biotech, social-media stocks rally in the past week 5:52 p.m. July 25, 2014 - blogs.marketwatch.com
Stocks bounce back Friday, end with gains for the week: live blog recap 3:21 p.m. July 18, 2014 - blogs.marketwatch.com
Another bear market for froth stocks? 3:03 p.m. July 17, 2014 - John Nyaradi
U.S. stocks gain; Dow sets its 15th record of the year 4:03 p.m. July 16, 2014 - Barbara Kollmeyer
U.S. stocks close lower; Dow ekes out a gain 4:16 p.m. July 15, 2014 - Barbara Kollmeyer
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap 3:04 p.m. July 15, 2014 - blogs.marketwatch.com
Social-media and biotech stocks weaker after Fed warning 10:23 a.m. July 15, 2014 - Steve Goldstein
U.S. stocks fall; momentum plays hit hard 4:20 p.m. July 8, 2014 - Barbara Kollmeyer
Dow falls by triple digits, closes back under 17,000: stock market live blog recap 3:51 p.m. July 8, 2014 - blogs.marketwatch.com
Momentum mauled: Biotech, Facebook, Twitter hit hard 12:32 p.m. July 8, 2014 - blogs.marketwatch.com

I Agree With Yellen, Sell Biotech Right Now 1:52 p.m. Sept. 27, 2014 - Seeking Alpha
3 Innovative Biotech Stocks to Diversify Your Portfolio 8:50 a.m. Sept. 26, 2014 - InvestorPlace.com
'Fast Money' Recap: How to Trade After the Market's Drop 5:00 a.m. Sept. 26, 2014 - TheStreet.com
How Far Will This Correction Go? 9:59 p.m. Sept. 25, 2014 - InvestorPlace.com
Following Biotech Stocks After Price Declines Of Greater Than 50% 4:03 p.m. Sept. 25, 2014 - Seeking Alpha
Biogen (BIIB) Flexes Its Biotech Biceps 2:04 a.m. Sept. 25, 2014 - InvestorPlace.com
Divergences Raise Yellow Flag for Traders 9:32 p.m. Sept. 24, 2014 - InvestorPlace.com
BioShares Plans Two Innovative Biotech ETFs - ETF News And Commentary 8:00 a.m. Sept. 24, 2014 - Zacks.com
You Can Live Without This Biotech CEF 12:44 p.m. Sept. 23, 2014 - Seeking Alpha
‘Generals’ Lead the Market Charge; Should You Worry? 9:22 p.m. Sept. 18, 2014 - InvestorPlace.com
Don’t Stick Your Neck Out Unnecessarily Today 9:26 p.m. Sept. 16, 2014 - InvestorPlace.com
3 Hot Ways to Play the Biotechnology Bonanza 6:36 a.m. Sept. 16, 2014 - InvestorPlace.com
'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks 5:00 a.m. Sept. 16, 2014 - TheStreet.com
Dow, Nasdaq Teetering on Key Support Lines 9:24 p.m. Sept. 15, 2014 - InvestorPlace.com
Viking Therapeutics debuts this week 3:41 p.m. Sept. 14, 2014 - Seeking Alpha
Tokai Pharma IPO slated for this week 3:28 p.m. Sept. 14, 2014 - Seeking Alpha
rEVO Biologics IPO set for this week 3:15 p.m. Sept. 14, 2014 - Seeking Alpha
ProQR Therapeutics debuts this week 2:55 p.m. Sept. 14, 2014 - Seeking Alpha
Foamix Pharma debuts this week 2:39 p.m. Sept. 14, 2014 - Seeking Alpha
No, You SHOULDN’T Buy Alibaba Through an IPO ETF 4:54 a.m. Sept. 12, 2014 - InvestorPlace.com

Premier Biomedical Advances Technology via Partnerships 10:29 a.m. May 9, 2014 - ACCESSWIRE
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 9:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 9:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 9:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 6:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 8:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 8:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 8:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 9:05 a.m. Dec. 16, 2013 - GlobeNewswire
Galectin Stands Out in 2013 with Liver Fibrosis Drug 12:06 p.m. Oct. 14, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 9:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 9:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 8:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 8:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP 8:41 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, HALO, MNKD and PDLI 8:30 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 9:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALXN, AMGN, CBST and CLDX 8:50 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, CYTK, ISIS and SRPT 8:40 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ANAC, RPRX, THLD and THRX 8:52 a.m. July 17, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OneAscent Welcomes Monica Stoudemire as New CCO

New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...

RTI's $14M Boost: A Game-Changer for Tech Innovators

Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...

K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Moore Law Investigates Aardvark Therapeutics' Risks

Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...

AbbVie's Bold Leap in Menstrual Migraine Treatment

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Helio Fred Garcia Honored by Diversity Action Alliance

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Unpacking RAGEism: Power Dynamics in U.S. Policies

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Atli Launches: AI-Powered eSIM Revolutionizes Travel

What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...

SES Sells to AFC Industries: A Strategic M&A Move

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...